Ali Seddighzadeh

1.1k total citations
23 papers, 751 citations indexed

About

Ali Seddighzadeh is a scholar working on Pathology and Forensic Medicine, Internal Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Ali Seddighzadeh has authored 23 papers receiving a total of 751 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pathology and Forensic Medicine, 9 papers in Internal Medicine and 6 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Ali Seddighzadeh's work include Multiple Sclerosis Research Studies (10 papers), Venous Thromboembolism Diagnosis and Management (9 papers) and Central Venous Catheters and Hemodialysis (6 papers). Ali Seddighzadeh is often cited by papers focused on Multiple Sclerosis Research Studies (10 papers), Venous Thromboembolism Diagnosis and Management (9 papers) and Central Venous Catheters and Hemodialysis (6 papers). Ali Seddighzadeh collaborates with scholars based in United States, Germany and Canada. Ali Seddighzadeh's co-authors include Samuel Z. Goldhaber, Gregory Piazza, Serena Hung, Peter A. Calabresi, Ying Zhu, Aaron Deykin, Douglas L. Arnold, Laura J. Balcer, Alexey Boyко and Jean Pelletier and has published in prestigious journals such as Neurology, The Lancet Neurology and CHEST Journal.

In The Last Decade

Ali Seddighzadeh

23 papers receiving 723 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ali Seddighzadeh United States 12 375 253 184 179 160 23 751
María José Forner Spain 16 50 0.1× 72 0.3× 39 0.2× 108 0.6× 128 0.8× 37 772
G Weissbach Germany 10 138 0.4× 40 0.2× 111 0.6× 42 0.2× 21 0.1× 40 437
Sabine Mainbourg France 10 28 0.1× 127 0.5× 77 0.4× 39 0.2× 110 0.7× 31 494
Su-Chun Cheng United States 11 113 0.3× 32 0.1× 46 0.3× 27 0.2× 37 0.2× 16 586
Ghaleb Elyamany Saudi Arabia 11 69 0.2× 96 0.4× 11 0.1× 61 0.3× 11 0.1× 49 393
B.H.R. Stack United Kingdom 15 60 0.2× 99 0.4× 23 0.1× 24 0.1× 37 0.2× 35 772
Jon Helgestad Denmark 11 43 0.1× 109 0.4× 67 0.4× 29 0.2× 6 0.0× 30 448
Hester A. de Groot‐Kruseman Netherlands 16 53 0.1× 19 0.1× 36 0.2× 31 0.2× 24 0.1× 43 988
L. Guillevin France 11 249 0.7× 12 0.0× 27 0.1× 24 0.1× 144 0.9× 28 678
Devis Benfaremo Italy 18 106 0.3× 25 0.1× 78 0.4× 12 0.1× 272 1.7× 53 773

Countries citing papers authored by Ali Seddighzadeh

Since Specialization
Citations

This map shows the geographic impact of Ali Seddighzadeh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ali Seddighzadeh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ali Seddighzadeh more than expected).

Fields of papers citing papers by Ali Seddighzadeh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ali Seddighzadeh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ali Seddighzadeh. The network helps show where Ali Seddighzadeh may publish in the future.

Co-authorship network of co-authors of Ali Seddighzadeh

This figure shows the co-authorship network connecting the top 25 collaborators of Ali Seddighzadeh. A scholar is included among the top collaborators of Ali Seddighzadeh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ali Seddighzadeh. Ali Seddighzadeh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Michael, Mini, Georges Deschênes, Pierre Cochat, et al.. (2020). ILLUMINATE-B, a Phase 3 Open-Label Study to Evaluate Lumasiran, an RNAi Therapeutic, in Young Children with Primary Hyperoxaluria Type 1 (PH1). Journal of the American Society of Nephrology. 31(10S). 515–515. 5 indexed citations
2.
Hu, Xiao, Yaming Hang, Yue Cui, et al.. (2017). Population‐Based Pharmacokinetic and Exposure‐Efficacy Analyses of Peginterferon Beta‐1a in Patients With Relapsing Multiple Sclerosis. The Journal of Clinical Pharmacology. 57(8). 1005–1016. 4 indexed citations
3.
White, Joleen T., Scott D. Newsome, Bernd C. Kieseier, et al.. (2016). Incidence, characterization, and clinical impact analysis of peginterferon beta1a immunogenicity in patients with multiple sclerosis in the ADVANCE trial. Therapeutic Advances in Neurological Disorders. 9(4). 239–249. 25 indexed citations
4.
Hu, Xiao, Shulian Shang, Ivan Nestorov, et al.. (2016). COMPARE: Pharmacokinetic profiles of subcutaneous peginterferon beta‐1a and subcutaneous interferon beta‐1a over 2 weeks in healthy subjects. British Journal of Clinical Pharmacology. 82(2). 380–388. 26 indexed citations
5.
Seddighzadeh, Ali, Serena Hung, Krzysztof Selmaj, et al.. (2014). Single-use autoinjector for peginterferon-β 1a treatment of relapsing-remitting multiple sclerosis: safety, tolerability and patient evaluation data from the Phase IIIb ATTAIN study. Expert Opinion on Drug Delivery. 11(11). 1713–1720. 12 indexed citations
6.
Hu, Xiao, Ali Seddighzadeh, Ying Zhu, et al.. (2014). Pharmacokinetics, pharmacodynamics, and safety of peginterferon beta‐1a in subjects with normal or impaired renal function. The Journal of Clinical Pharmacology. 55(2). 179–188. 8 indexed citations
7.
Calabresi, Peter A., Douglas L. Arnold, Laura J. Balcer, et al.. (2014). Pegylated interferon beta-1a for relapsing-remitting multiple sclerosis (ADVANCE): a randomised, phase 3, double-blind study. The Lancet Neurology. 13(7). 657–665. 288 indexed citations
8.
9.
Kieseier, Bernd C., Douglas L. Arnold, Laura J. Balcer, et al.. (2014). Peginterferon beta-1a in multiple sclerosis: 2-year results from ADVANCE. Multiple Sclerosis Journal. 21(8). 1025–1035. 84 indexed citations
10.
11.
Seddighzadeh, Ali, et al.. (2009). Strains ofEhrlichia chaffeensisin Southern Indiana, Kentucky, Mississippi, and North Carolina. Journal of Medical Entomology. 46(6). 1468–1473. 4 indexed citations
12.
Calfon, Marcella A., Ali Seddighzadeh, Gregory Piazza, & Samuel Z. Goldhaber. (2009). Deep Vein Thrombosis in Orthopedic Surgery. Clinical and Applied Thrombosis/Hemostasis. 15(5). 512–516. 10 indexed citations
13.
Seddighzadeh, Ali, et al.. (2008). Deep vein thrombosis in patients with chronic kidney disease. Thrombosis and Haemostasis. 99(6). 1035–1039. 29 indexed citations
14.
Piazza, Gregory, Ali Seddighzadeh, & Samuel Z. Goldhaber. (2008). Heart Failure in Patients With Deep Vein Thrombosis. The American Journal of Cardiology. 101(7). 1056–1059. 32 indexed citations
15.
Seddighzadeh, Ali, et al.. (2008). Gastrointestinal Complications After 3 Months of Dual Antiplatelet Therapy for Drug-eluting Stents as Assessed by Wireless Capsule Endoscopy. Clinical and Applied Thrombosis/Hemostasis. 15(2). 171–176. 4 indexed citations
16.
Piazza, Gregory, Ali Seddighzadeh, & Samuel Z. Goldhaber. (2007). Double Trouble for 2,609 Hospitalized Medical Patients Who Developed Deep Vein Thrombosis. CHEST Journal. 132(2). 554–561. 78 indexed citations
17.
Seddighzadeh, Ali, Urszula Zurawska, Ranjith Shetty, & Samuel Z. Goldhaber. (2007). Venous thromboembolism in patients undergoing surgery: Low rates of prophylaxis and high rates of filter insertion. Thrombosis and Haemostasis. 98(12). 1220–1225. 18 indexed citations
18.
Shetty, Ranjith, Ali Seddighzadeh, Gregory Piazza, & Samuel Z. Goldhaber. (2007). Chronic obstructive pulmonary disease and deep vein thrombosis: a prevalent combination. Journal of Thrombosis and Thrombolysis. 26(1). 35–40. 29 indexed citations
19.
Piazza, Gregory, Ali Seddighzadeh, & Samuel Z. Goldhaber. (2007). Deep-Vein Thrombosis in the Elderly. Clinical and Applied Thrombosis/Hemostasis. 14(4). 393–398. 32 indexed citations
20.
Seddighzadeh, Ali, Ranjith Shetty, & Samuel Z. Goldhaber. (2007). 1,096 CANCER PATIENTS WITH DVT: LOWER PROPHYLAXIS RATES BUT MORE FREQUENT INFERIOR VENA CAVA FILTER INSERTION. CHEST Journal. 132(4). 499A–499A. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by María José Forner Breakdown of academic impact, for papers by G Weissbach Breakdown of academic impact, for papers by Sabine Mainbourg Breakdown of academic impact, for papers by Su-Chun Cheng Breakdown of academic impact, for papers by Ghaleb Elyamany Breakdown of academic impact, for papers by B.H.R. Stack Breakdown of academic impact, for papers by Jon Helgestad Breakdown of academic impact, for papers by Hester A. de Groot‐Kruseman Breakdown of academic impact, for papers by L. Guillevin Breakdown of academic impact, for papers by Devis Benfaremo
Rankless by CCL
2026